Tag: Optinose
Paratek expands commercial portfolio with Optinose
Paratek Pharmaceuticals has recently finalized the acquisition of Optinose, a deal valued at nearly $330 million. This strategic…
Paratek Pharmaceuticals has recently finalized the acquisition of Optinose, a deal valued at nearly $330 million. This strategic…